Literature DB >> 883815

Pharmacokinetic study of netilmicin.

B R Meyers, S Z Hirschman, G Wormser, D Siegel.   

Abstract

Netilmicin at a dose of 2 mg/kg was infused intravenously into 10 healthy volunteers. A peak serum concentration of 16.56 mug/ml was obtained at the end of the infusion. Thirty-nine percent of the infused dose was excreted in the urine during the first 8 h after infusion. The pharmacokinetic parameters of netilmicin were derived by analyzing the elimination data according to a two-compartment model.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 883815      PMCID: PMC352165          DOI: 10.1128/AAC.12.1.122

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  8 in total

1.  Drug therapy. Clinical Pharmacokinetics (first of two parts).

Authors:  D J Greenblatt; J Kock-Weser
Journal:  N Engl J Med       Date:  1975-10-02       Impact factor: 91.245

2.  Pharmacologic studies on tobramycin and comparison with gentamicin.

Authors:  B R Meyers; S Z Hirschman
Journal:  J Clin Pharmacol New Drugs       Date:  1972 Aug-Sep

3.  Assessment of pharmacokinetic constants from postinfusion blood curves obtained after I.V. infusion.

Authors:  J C Loo; S Riegelman
Journal:  J Pharm Sci       Date:  1970-01       Impact factor: 3.534

4.  Biological activity of netilmicin, a broad-spectrum semisynthetic aminoglycoside antibiotic.

Authors:  G H Miller; G Arcieri; M J Weinstein; J A Waitz
Journal:  Antimicrob Agents Chemother       Date:  1976-11       Impact factor: 5.191

5.  Comparative nephrotoxicities of netilmicin and gentamicin in rats.

Authors:  F C Luft; M N Yum; S A Kleit
Journal:  Antimicrob Agents Chemother       Date:  1976-11       Impact factor: 5.191

6.  Bactericidal efficacy of Sch 20569 and amikacin against gentamicin-sensitive and -resistant organisms.

Authors:  J J Rahal; M S Simberkoff; K Kagan; N H Moldover
Journal:  Antimicrob Agents Chemother       Date:  1976-04       Impact factor: 5.191

7.  Antimicrobial activity in vitro of netilmicin and comparison with sisomicin, gentamicin, and tobramycin.

Authors:  B R Meyers; S Z Hirschman
Journal:  Antimicrob Agents Chemother       Date:  1977-01       Impact factor: 5.191

8.  Pharmacokinetic parameters of sisomicin.

Authors:  B R Meyers; S Z Hirschman; S Yancovitz; B Ribner
Journal:  Antimicrob Agents Chemother       Date:  1976-07       Impact factor: 5.191

  8 in total
  10 in total

1.  Predicted tissue accumulation of netilmicin in patients.

Authors:  D J Edwards; A Mangione; T J Cumbo; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1981-12       Impact factor: 5.191

2.  Tentative interpretive criteria for the diffusion susceptibility test using 30-microgram netilmicin disks.

Authors:  R N Jones; A L Barry; C Thornsberry
Journal:  Antimicrob Agents Chemother       Date:  1980-09       Impact factor: 5.191

3.  Comparison of netilmicin and gentamicin pharmacokinetics in humans.

Authors:  M Chung; R Costello; S Symchowicz
Journal:  Antimicrob Agents Chemother       Date:  1980-02       Impact factor: 5.191

4.  Modification of interpretive breakpoints for netilmicin disk susceptibility tests with Pseudomonas aeruginosa.

Authors:  A L Barry; G H Miller; R S Hare; R N Jones; C Thornsberry
Journal:  J Clin Microbiol       Date:  1984-03       Impact factor: 5.948

5.  Pharmacokinetics of netilmicin in children with and without cystic fibrosis.

Authors:  H Michalsen; T Bergan
Journal:  Antimicrob Agents Chemother       Date:  1981-06       Impact factor: 5.191

6.  Pharmacology and efficacy of netilmicin.

Authors:  I Trestman; J Parsons; J Santoro; G Goodhart; D Kaye
Journal:  Antimicrob Agents Chemother       Date:  1978-05       Impact factor: 5.191

7.  Pharmacokinetic properties of netilmicin in newborn infants.

Authors:  J D Siegel; G H McCracken; M L Thomas; N Threlkeld
Journal:  Antimicrob Agents Chemother       Date:  1979-02       Impact factor: 5.191

8.  Pharmacokinetic assessment of netilmicin in newborns and older children.

Authors:  T Bergan; H Michalsen
Journal:  Infection       Date:  1982       Impact factor: 3.553

9.  Pharmacokinetics of netilmicin in the presence of normal or impaired renal function.

Authors:  G Humbert; A Leroy; J P Fillastre; G Oksenhendler
Journal:  Antimicrob Agents Chemother       Date:  1978-07       Impact factor: 5.191

Review 10.  Netilmicin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; S Chaplin; R H Sayce; K L Goa
Journal:  Drugs       Date:  1989-11       Impact factor: 9.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.